Prominence slow acetylator phenotype patients sulfonamide hypersensitivity reactions Delayed hypersensitivity reactions severe adverse effects sulfonamides current clinical use reactions differences metabolism detoxification reactive metabolites sulfonamides N-Acetylation major metabolic pathway sulfonamides Slow acetylation phenotype risk factor development reactions acetylation phenotype patients hypersensitivity reactions sulfonamides females males group mean age years age range years acetylator phenotype ratio urinary caffeine metabolites oral dose mg caffeine Nineteen patients slow acetylators incidence slow acetylators race-matched control population slow acetylator phenotype risk factor development sulfonamide hypersensitivity reactions support role imbalances pathways metabolism detoxification sulfonamides pathogenesis reactions 